Chemical nomenclature

Chemical nomenclature is the collection of rule-governed systems used to assign names to chemical compounds. The international standard is maintained by IUPAC (the International Union of Pure and Applied Chemistry), which builds systematic names from roots, prefixes, and suffixes that together encode a molecule's exact structure. Alongside formal IUPAC names, chemistry relies on a parallel world of common names and field-specific family conventions.

In psychoactive pharmacology, these informal traditions carry dense structural information. Alexander Shulgin's series names — 2C, TMA, DOM — each encode a shared phenethylamine or tryptamine scaffold. The bk- prefix marks a beta-keto modification at a specific carbon position; the -azine suffix signals membership in the phenothiazine family. These shorthands let researchers and readers place a compound within its chemical lineage at a glance, without parsing a full IUPAC string.

How it works · its role

An IUPAC name is assembled from a parent chain or ring system, substituent names attached as prefixes or suffixes, and position numbers that specify exactly where each group sits on the structure. The result is unambiguous — a systematic name fully specifies a molecule — but often unwieldy in practice, which is why trivial names and family conventions persist alongside it.

Family conventions trade completeness for legibility. In the 2C series (2C-B, 2C-I, 2C-E), "2C" denotes a phenethylamine with methoxy groups at positions 2 and 5 of the benzene ring; the trailing letter identifies the substituent at position 4. The bk- prefix places a ketone at the beta-carbon, a modification that shifts metabolism and alters how quickly the body clears the compound. Suffixes do similar work at scale: -pam places a compound among the benzodiazepines; -amine signals a nitrogen-bearing functional group; -ine frequently marks an alkaloid.

Relevance to substances & effects

Understanding these conventions makes substance pages more legible. When an unfamiliar name appears, its roots and affixes often place it within a known structural class before any further reading — a useful anchor when navigating a dense pharmacology section or an interaction table.

The critical caveat is that structural proximity in a name does not reliably predict pharmacological proximity. Two compounds sharing a scaffold can differ sharply in receptor affinity, potency, duration, and safety profile. The bk- modification, for example, alters metabolic pathways enough that bk-MDMA (methylone) has a meaningfully different duration and distinct toxicology from MDMA, despite their close structural relationship. Classic psychedelics and their non-psychedelic structural analogues illustrate the same principle at a larger scale.

Names describe structure. They do not describe effect, potency, or risk. Holding that distinction clearly is one of the most useful frames for reading any pharmacological reference on this site.